PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsTilarginine
Tilarginine
Tilarginine is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target nitric oxide synthase, inducible, nitric oxide synthase 3, and nitric oxide synthase 1.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
No data
Commercial
No data
Clinical
No data
Drug
General
Drug common nameTilarginine
INNtilarginine
Description
N-Methylarginine is an inhibitor of nitric oxide synthase. Chemically, it is a methyl derivative of the amino acid arginine. It is used as a biochemical tool in the study of physiological role of nitric oxide.
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CNC(=N)NCCC[C@H](N)C(=O)O
Identifiers
PDB
CAS-ID17035-90-4
RxCUI
ChEMBL IDCHEMBL256147
ChEBI ID28229
PubChem CID4366
DrugBank
UNII ID27JT06E6GR (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
NOS2
NOS2
NOS3
NOS3
NOS1
NOS1
Organism
Homo sapiens
Gene name
NOS2
Gene synonyms
NOS2A
NCBI Gene ID
Protein name
nitric oxide synthase, inducible
Protein synonyms
HEP-NOS, Hepatocyte NOS, Inducible NO synthase, Inducible NOS, iNOS, nitric oxide synthase 2, inducible, nitric oxide synthase 2A (inducible, hepatocytes), nitric oxide synthase, macrophage, NOS type II, NOS, type II, Peptidyl-cysteine S-nitrosylase NOS2
Uniprot ID
Mouse ortholog
Nos2 (18126)
nitric oxide synthase, inducible (Q8R410)
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use